Shivani Gupta, DO
Physical Medicine & Rehabilitation · Oak Lawn, ILNPI 1467864389
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $161,820 of the $200,599 with a category attached, or 80.7%. Ipsen Biopharmaceuticals, Inc accounts for 96.4% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $73,112, more than ten times the $184 reported in 2020. Among physical medicine & rehabilitation clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $907.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$193K
- AbbVie$5K
- Ipsen Pharma SAS$841
- Merz Pharmaceuticals, LLC$298
- Medtronic$282
- Piramal Critical Care$205
- plus $485 from 14 others
What the payments were for
- Consulting fees$7,7504%
- Speaking & faculty fees$161,82081%
- Travel & lodging$24,74712%
- Food & beverage$6,2823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 156 | $193,320 |
| AbbVie(2 entities) | 20 | $5,169 |
| Ipsen Pharma SAS | 2 | $841 |
| Merz Pharmaceuticals, LLC | 4 | $298 |
| Medtronic(2 entities) | 6 | $282 |
| Piramal Critical Care | 5 | $205 |
| Amgen | 8 | $145 |
| Biodelivery Sciences International, Inc. | 3 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $35 |
| Biogen | 2 | $33 |
| UCB, Inc. | 2 | $32 |
| Revance Therapeutics, Inc. | 1 | $20 |
| MDD US Operations, LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DYSPORT$192,576
- BOTOX$4,875
- SYNCHROMED$140
- XEOMIN$125
How this compares
$200,599 in reported general payments places this provider in the 95th percentile of 433 physical medicine & rehabilitation providers in Illinois.
See all physical medicine & rehabilitation providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $1,343 |
| Baclofen | 78 | $1,240 |
| Pregabalin | 15 | $482 |
| Gabapentin | 38 | $425 |
| Tizanidine Hcl | 26 | $244 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Oak Lawn
- Anterpreet SinghOak Lawn$4K
- Zachary McCormickChicago$290K
- David SchneiderBarrington$30K
- Hugh McDermottMaywood$22K
- Prasanth KattaSycamore$19K
- Ravi KasiChicago$17K
- Steven KreisChicago$16K
- Henry GuanChicago$11K
- Ibrahim Usman-OyoweChicago$10K
- David RosaniaHinsdale$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.